Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
Rhea-AI Summary
Healthcare Triangle (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19 million, a 158% year-over-year increase, with gross profit rising 322% to $2.07 million. Gross margin expanded to 22.5% from 13.8%, driven largely by its AI-powered customer engagement platform.
The AI platform contributed $6.31 million in Q2 revenue, about 69% of the total, and generated $1.64 million in segment gross profit at roughly 26% margin. For the first half of 2026, revenue reached $19.05 million and gross profit $4.46 million, up 162% and 444% year over year, respectively, with gross margin at 23.4%. Stockholders' equity increased to $49.1 million as of June 30, 2026, from $9.9 million at year-end 2025, reflecting a stronger balance sheet.
Positive
- Q2 2026 revenue $9.19M, up 158% year over year
- Q2 2026 gross profit $2.07M, up 322% year over year
- Q2 2026 gross margin 22.5%, up 8.7 percentage points from 13.8%
- H1 2026 revenue $19.05M, up 162% year over year
- H1 2026 gross profit $4.46M, up 444% year over year
- Stockholders’ equity increased to $49.1M from $9.9M at Dec. 31, 2025
Negative
- None.
News Explained
The acquisition is already reflected in Q2 operations; the latest supplied cash figure still dates to March 31, not June 30.
The release reports completed Q2 2026 results and says the January acquisition of Teyame and Datono was the primary operating driver, with the acquired businesses contributing
Because the acquisition was completed through a wholly owned subsidiary, that contribution is presented as part of HCTI’s reported operations rather than as a prospective target or planned transaction.
For liquidity context, the latest supplied cash-and-equivalents figure was
Sources and calculations
- Healthcare Triangle Q2 2026 results release (2026-08-13)
- Healthcare Triangle Q1 2026 fundamentals (2026Q1)
- Cash and equivalents vs quarterly operating cash outflow, in days of cash use $4,315,000 / ($6,864,000 / 90) = [object Object]
Market Reaction – HCTI
Following this news, HCTI has gained 2.42%, reflecting a moderate positive market reaction. Argus tracked a peak move of +19.2% during the session. Our momentum scanner has triggered 19 alerts so far, indicating notable trading interest and price volatility. The stock is currently trading at $1.27. Trading volume is exceptionally heavy at 689.1x the average, suggesting very strong buying interest.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 06 | client revenue update | Positive | +10.2% | Teyame matched a full year's client revenue in six months |
| Jul 29 | acquisition proposal | Positive | -26.6% | Non-binding proposal sought a 51% CosmoInnovations equity stake |
| Jul 29 | share issuance | Negative | -4.3% | Company issued 12,546,540 shares tied to legacy transactions |
| Jul 27 | subsidiary launch | Positive | +4.9% | Healthcare Triangle created Purpose Health and appointed new leadership |
| Jun 12 | private placement | Negative | -8.2% | Company completed a convertible note financing generating gross proceeds |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
HCTI's recent news reactions generally aligned with announcement direction, although the proposed acquisition produced a sharp negative divergence.
Key Terms
omnichannel technical
stockholders' equity financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
AI-Powered Customer Engagement Segment Contributed
Building on the momentum from the first quarter, the Company's results continue to reflect the transformative impact of its January 2026 acquisition of Teyame 360 S.L. ("Teyame") and Datono Mediacion S.L. ("Datono"), which contributed to a second consecutive quarter of triple-digit revenue and gross profit growth, alongside meaningful improvements to the Company's balance sheet and liquidity position.
Q2 2026 Financial Highlights
Q2 2026 | Q2 2025 | Change | |
Total Revenue | +158 % | ||
Gross Profit | +322 % | ||
Gross Margin | 22.5 % | 13.8 % | +8.7 pts |
Six Months Ended June 30, 2026 Financial Highlights
H1 2026 | H1 2025 | Change | |
Total Revenue | +162 % | ||
Gross Profit | +444 % | ||
Gross Margin | 23.4 % | 11.3 % | +12.1 pts |
The Teyame and Datono Acquisition: Sustained Momentum in the Second Quarter
The Teyame and Datono acquisition, completed through the Company's wholly owned subsidiary Teyame AI Holdings Inc., remained the primary driver of HCTI's financial performance in the second quarter. The acquired businesses, which operate as an integrated AI-powered omnichannel customer experience, marketing, and financial and insurance distribution platform, contributed
The Customer Engagement Services segment generated
Balance Sheet and Liquidity Highlights
Alongside its operating results, the Company took several actions during the second quarter to strengthen its financial position. Total stockholders' equity increased to
David Ayanoglou, Chief Financial Officer of Healthcare Triangle, said:
"Our second quarter results demonstrate that the strong performance we saw immediately following the Teyame and Datono acquisition was not a one-time event. The Customer Engagement Services segment again contributed nearly
About Healthcare Triangle
Healthcare Triangle, Inc. based in Pleasanton, California, reinforces healthcare progress through breakthrough technology and extensive industry knowledge and expertise. We support healthcare organizations including hospitals and health systems, payers, and pharma/life sciences organizations in their effort to improve health outcomes through better utilization of the data and information technologies that they rely on. Healthcare Triangle achieves HITRUST Certification for Cloud and Data Platform (CaDP), marketed as CloudEz™ and DataEz™. HITRUST Risk-based, 2-year (r2) Certified status demonstrates to our clients the highest standards for data protection and information security. Healthcare Triangle enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs and competitive threats. The highly regulated healthcare and life sciences industries rely on Healthcare Triangle for expertise in digital transformation encompassing the cloud, security and compliance, data lifecycle management, healthcare interoperability, and clinical & business performance optimization.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995), and include, among others, statements regarding the Company's future financial and operating performance, the anticipated benefits of the Teyame and Datono acquisition, and expected trends in the Company's business. Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties, and assumptions, including market and other conditions. Actual results could differ materially from current projections or implied results. Investors should read the risk factors outlined in the Company's annual report on Form 10-K for the year ended December 31, 2025, on file with the Securities and Exchange Commission (the "SEC") and in previous filings, subsequent filings and future periodic reports filed with the SEC. All the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
Investors
1-800-617-9550
ir@healthcaretriangle.com
View original content:https://www.prnewswire.com/news-releases/healthcare-triangle-reports-322-increase-in-gross-profit-and-158-increase-in-revenue-for-q2-2026-302850835.html
SOURCE Healthcare Triangle, Inc.